High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.
about
Human CD8+ CD57- TEMRA cells: Too young to be called "old"Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases.Identification of minor histocompatibility antigens based on the 1000 Genomes ProjectHigh-throughput identification of antigen-specific TCRs by TCR gene capture.Broadening the repertoire of melanoma-associated T-cell epitopes.Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantationThe Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants.Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells.Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives.T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.Mixed functional characteristics correlating with TCR-ligand koff -rate of MHC-tetramer reactive T cells within the naive T-cell repertoire.The human leukocyte antigen-presented ligandome of B lymphocytes.Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.Identification of a novel UTY-encoded minor histocompatibility antigen.Analysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project
P2860
Q33648329-622015B3-74A7-46C4-91F0-77E10C0AE2CCQ34529083-713E59AC-10BD-486E-8AF3-1E8936E1EED0Q34648976-51A870C2-DFED-4F98-B7DD-A5935185FC90Q35016476-C9433012-1B76-41E7-AF68-DF3C5C23366DQ35546276-A23A40D4-61EB-4AD9-9713-6B6E2749BCB0Q35588845-5F701D5B-084C-4433-BBBA-F6C88BA66C9BQ36129950-F0E13877-01CC-48F1-A13F-0C9295C2EF6BQ37119456-9EC0E6F7-6D62-40D8-B9CE-D34AAD0F16DEQ37726682-7B735888-133D-413B-88CE-62103A267E65Q38572657-A676E048-CDE3-4669-BDE4-70144BE63AD0Q38616461-81798CB8-EE56-4B3D-9728-EF5803D1C808Q38871209-73FC0C27-8C80-4D87-A970-06EE2C0A2E95Q39119176-6308B270-A489-425B-9A21-39881EB3B743Q39182194-E28BE925-B3C6-43A7-907A-9CF283267798Q41368439-DE22F88D-F8CB-4507-812E-A4F3539D1E7BQ51343627-9C07ED78-F861-4190-8E2C-F411D42BB1F3Q58773669-3681B618-8D56-45D1-9008-947266E1B542
P2860
High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High-throughput identification ...... : feasibility and limitations.
@ast
High-throughput identification ...... : feasibility and limitations.
@en
type
label
High-throughput identification ...... : feasibility and limitations.
@ast
High-throughput identification ...... : feasibility and limitations.
@en
prefLabel
High-throughput identification ...... : feasibility and limitations.
@ast
High-throughput identification ...... : feasibility and limitations.
@en
P2093
P2860
P1433
P1476
High-throughput identification ...... : feasibility and limitations.
@en
P2093
Arne Bakker
J H Frederik Falkenburg
Michel G D Kester
Mirjam H M Heemskerk
Peter A von dem Borne
Pleun Hombrink
Sine R Hadrup
Ton N M Schumacher
P2860
P304
P356
10.1371/JOURNAL.PONE.0022523
P407
P577
2011-08-05T00:00:00Z